eBook: Phenotypic Screening Advances

Not so long ago, phenotypic screening was the only strategy for drug discovery. It was fairly successful, ultimately leading to the development of many first-in-class therapeutics. Then it was shunted aside for target-based discovery methods, which have not lived up to expectations. Now many pharmaceutical companies are implementing a more balanced strategy that utilizes both phenotypic and target-based approaches. But challenges remain, particularly with suspension cells, primary cells, and heterogeneous cell cultures.

Download this eBook to learn more about the benefits of phenotypic screening, as well as some of the most burdensome challenges and the novel solutions that are emerging to address them.

Complete the form to download